Logo

Richard Taylor

Sep 03, 2008
Premium

Richard Taylor has joined Vermillion as senior financial consultant and interim CFO. He succeeds Qun Zhou, who had been serving as interim CFO. Taylor was VP of finance and administration at Cellgate, a privately held oncology company. Since that firm's acquisition by Progen Pharmaceuticals, he has served as head of finance, US operations for Progen under a post-merger, short-term contract.

Filed under

Diagnostics
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.